MARINUS PHARMACEUTICALS INC (MRNS) Stock Income Statement
USA - NASDAQ:MRNS - US56854Q2003 - Common Stock
0.55 USD
+0 (+0.09%)
0.5491 USD
0 (-0.16%)
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.47M | 30.99M | 25.48M | 15.35M | 1.72M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 3.09M | 1.93M | 1.51M | 1.48M | null | |||
| Gross Profit | 28.37M | 29.05M | 23.97M | 13.87M | null | |||
| Operating Expenses | 151.00M | 160.54M | 136.76M | 110.80M | 69.66M | |||
| Research and Development | 87.73M | 99.39M | 79.91M | 73.52M | 51.11M | |||
| Selling, General, and Administrative Expenses | 63.27M | 61.15M | 56.85M | 37.28M | 18.55M | |||
| Operating Income | -122.62M | -131.49M | -112.79M | -95.45M | -67.94M | |||
| Interest Income/Expense | -12.19M | -8.78M | -8.32M | -2.50M | 500.00K | |||
| Other Income/Expense | 271.00K | 1.42M | -1.90M | 860.00K | -40.00K | |||
| Non Recurring Items | null | -100.00K | -800.00K | -1.68M | null | |||
| Income Before Taxes | -140.49M | -142.94M | -16.43M | -98.78M | -67.48M | |||
| Income Tax | null | -1.54M | 3.39M | null | null | |||
| Net Income | -140.49M | -141.41M | -19.82M | -98.78M | -76.36M | |||
| EBITDA | -122.10M | -130.93M | -112.37M | -95.09M | -67.61M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.46773 | -2.63096 | -0.51 | -2.69 | -2.8 | |||
| Non GAAP EPS | -2.4400000000000004 | -2.63 | -3.28 | -2.6900000000000004 | -2.58 | |||
| Statistics | ||||||||
| Gross Profit Margin | 90.17% | 93.76% | 94.07% | 90.36% | N/A | |||
| Profit Margin | -446.49% | -456.31% | -77.79% | -643.52% | -4439.53% | |||
| Operating Profit Margin | -389.70% | -424.30% | -442.66% | -621.82% | -3950.00% | |||
All data in USD